FY2027 Q1 was strong, with sales of ¥255.7 billion and profit from ordinary activities of approximately ¥82.4 billion. The H1 forecast is sales of ¥521.0 billion and the same profit measure of ¥165.0 billion, implying that Q2 alone would need to deliver approximately ¥265.3 billion in sales and ¥82.4 billion in profit.
All recorded disclosures and news since the latest annual or semiannual filing. Switching watchpoints keeps the full history. Select an item to inspect its source.2026-06-05 〜 2026-10-25 · 34 of 34 items
Scroll the timeline →
Whether Q1 sales of ¥255,742 million represented 49.1% progress against the H1 sales forecast of ¥521,000 million
How much of the H1 forecast of ¥165,000 million in profit from ordinary activities was secured against Q1 operating profit of ¥82,626 million
Whether Q2 standalone sales of ¥265,258 million and profit of ¥82,374 million, implied from the H1 forecast, were exceeded
Whether the full-year earnings forecast will remain undisclosed or the full-year outlook will be updated with the H1 results
FY2027 Q1 sales were ¥255,742 million, operating profit was ¥82,626 million, and profit for the quarter attributable to owners of the parent was ¥65,791 million. Year on year, sales increased 16.0%, operating profit 30.0% and net profit 26.9%. Growth in both Life Care and Information & Communications lifted the company's overall start to the year.
The H1 forecast presented by the company at 1Q was sales of ¥521,000 million, profit from ordinary activities of ¥165,000 million, profit before tax of ¥170,000 million and profit attributable to owners of the parent of ¥131,000 million. Q1 sales represented 49.1% of the H1 sales forecast and operating profit approximately 50.1% of the corresponding forecast, meaning that roughly half of the H1 forecast had been achieved numerically. However, Q1 operating profit includes the effects of foreign exchange and product mix, so full-year stability cannot be assessed from the progress rate alone.
Subtracting Q1 actual results from the H1 forecast implies standalone Q2 sales of ¥265,258 million and profit from ordinary activities of ¥82,374 million. This assumes that sales will increase approximately 3.7% from Q1 while profit will remain broadly flat, requiring the continued strength of high-margin Information & Communications products and improved profitability in Life Care in Q2. The H1 forecast does not assume that Q1's profit growth rate of around 30% will continue unchanged, and allows for some moderation in profit growth in Q2.
In the next results release, standalone Q2 sales and profit should be compared with the levels implied by the H1 forecast to determine whether Q1's strength reflected temporary demand pull-forward or the weaker yen. In addition, the company has not disclosed a full-year forecast because of foreign-exchange conditions and the business environment for end-consumer products. Whether it provides full-year guidance at H1 or defers it until the third quarter will therefore also be an important disclosure point.
Achieving the H1 forecast requires sales to increase further in Q2 while profit remains at roughly the Q1 level.
Select a value or step to inspect its source.
Ordered by date. Disclosures and financial records differ from news and company threads; open each source to inspect it.
2026-10-30 · Awaiting publication
· Awaiting publication
The prior-year comparison for this event
2025-10-31 disclosed · In ¥ millions; each quarter is cumulative from the start of the fiscal year. EPS is in yen.
Latest available: FY2027 Q1
Net salesBusiness scale
454,899JPY m
↗ +6.2% YoYOperating profitCore earnings
—JPY m
YoY unavailableNewest first. The highlighted column is this event’s comparison. YoY uses the same period and accounting basis.
| Metric | FY2027 Q1 | FY2026 full year | FY2026 Q3 | FY2026 Q2Comparison | FY2026 Q1 | FY2025 full year | FY2025 Q3 | FY2025 Q2 |
|---|---|---|---|---|---|---|---|---|
| Net sales | 255,742↗ +16.0% YoY | 947,749↗ +9.4% YoY | 699,619↗ +7.8% YoY | 454,899↗ +6.2% YoY | 220,406YoY unavailable | 866,032YoY unavailable | 649,276YoY unavailable | 428,430YoY unavailable |
| Operating profit | 82,626YoY unavailable | —YoY unavailable | —YoY unavailable | —YoY unavailable | —YoY unavailable | —YoY unavailable | —YoY unavailable | —YoY unavailable |
| Ordinary profit | —YoY unavailable | —YoY unavailable | —YoY unavailable | —YoY unavailable | —YoY unavailable | —YoY unavailable | —YoY unavailable | —YoY unavailable |
| Net income | 65,791↗ +26.9% YoY | 253,085↗ +25.2% YoY | 198,865↗ +32.1% YoY | 107,268↗ +7.2% YoY | 51,840YoY unavailable | 202,101YoY unavailable | 150,571YoY unavailable | 100,091YoY unavailable |
| Earnings per share | 196.61↗ +30.0% YoY | 743.93↗ +27.9% YoY | 582.87↗ +34.9% YoY | 313.19↗ +9.3% YoY | 151.24YoY unavailable | 581.45YoY unavailable | 431.99YoY unavailable | 286.64YoY unavailable |